Schedule 13D ownership disclosure
Aurinia Pharmaceuticals Inc
Common Shares, no par value · CUSIP: 05156V102
Event date: 2025-08-11
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ILJIN SNT Co., Ltd.Reported CIK 0001772596
Shares: 5,411,533.00 · Class: 4.1%
- ILJIN Steel Co., Ltd.
Shares: 1,123,608.00 · Class: 0.9%
- ILJIN GLS Co., Ltd.
Shares: 5,411,533.00 · Class: 4.1%
- Sae Kyoung Huh
Shares: 465,766.00 · Class: 0.4%
- Seoung Eun Huh
Shares: 392,188.00 · Class: 0.3%
- Chin Kyu Huh
Shares: 6,535,141.00 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-077809
- Form type
- SCHEDULE 13D/A
- Filer
- Aurinia Pharmaceuticals Inc.
- CIK
- CIK 1600620
- Filed
- Aug 13, 2025
- Reporting period
- Aug 11, 2025
- Description
- Schedule 13D beneficial ownership